BUZZ-Australia's Lumos Diagnostics hits 3-1/2-year high on sales jump

Reuters
2025/10/23
BUZZ-Australia's <a href="https://laohu8.com/S/LDXHF">Lumos Diagnostics</a> hits 3-1/2-year high on sales jump

** Shares of Lumos Diagnostics LDX.AX rise as much as 12.8% to A$0.265, highest level since May 12, 2022

** Q1 product revenue rises four-fold to $1.2 million, helped by increasing adoption of FebriDx across the U.S.

** FebriDx is co's rapid point of care test to help differentiate between bacterial and non-bacterial acute respiratory infections

** YTD, shares have risen more than seven-fold in value

(Reporting by Nichiket Sunil in Bengaluru)

((Nichiket.Sunil@thomsonreuters.com))

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10